Alicia McElhaney

Recent Articles By The Author

Skincare Makers Lead Biotech Movers

Skincare Makers Lead Biotech Movers

Paratek Pharmaceuticals soared while Foamix floundered ahead of market's open.

Mylan Hit After Abbott Dumps Shares

Mylan Hit After Abbott Dumps Shares

The company decreased its 13% stake in Mylan Friday.

Here's How to Invest in Hospital Stocks Ahead of AHCA Vote

Here's How to Invest in Hospital Stocks Ahead of AHCA Vote

Mizuho analyst Sheryl Skolnick says investing in credit sensitive equities is the best investment option.

Immunomedics, Mylan Lead Biotech Movers

Immunomedics, Mylan Lead Biotech Movers

Investors weren't completely distracted by the Affordable Care Act debate.

CFO Says Depomed to Buy or Be Sold

CFO Says Depomed to Buy or Be Sold

The biotech company will either pick up assets to grow or sell itself to a larger company in the space, its chief financial officer told a conference.

Sanofi Said to Be Near $1 Billion Deal for Flexion

Sanofi Said to Be Near $1 Billion Deal for Flexion

Flexion is an arthritis-focused biotech company.

Valeant CEO Compensation Revealed, Shares Climb

Valeant CEO Compensation Revealed, Shares Climb

CEO Joseph Papa takes home approximately $62.7 million yearly.

Valeant Closes Down Slightly After Completing Refi

Valeant Closes Down Slightly After Completing Refi

Valeant shares were down nearly 2% at one point on news that it has completed several refinancing transactions.

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.

Regenxbio Leads Biotech Movers Ahead of Market's Open

Regenxbio Leads Biotech Movers Ahead of Market's Open

Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.